Page last updated: 2024-08-25

suplatast tosilate and Disease Models, Animal

suplatast tosilate has been researched along with Disease Models, Animal in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Li, Y; Liu, D; Tan, Y; Zhong, L1
Ayyildiz, ZA; Bagriyanik, AH; Karaman, M; Karaman, O; Kiray, M; Tuncel, T; Uysal, P; Uzuner, N; Yilmaz, O1
Katayama, I; Nishioka, K; Sasaki, G; Satoh, T; Wu, MH; Yokozeki, H1
Hayashi, Y; Irimura, K; Kiniwa, M; Kirimoto, T; Matsuura, N; Nakano, K; Oka, T; Yoshimura, N1
Iijima, H; Liu, Y; Shirato, K; Tamura, G; Taniguchi, H1
Hamada, H; Hiwada, K; Kohno, N; Sakai, K; Yokoyama, A; Zhao, GD1
Abo, M; Fujimura, M; Ishiura, Y; Kita, T; Kurashima, K; Myou, S; Nakao, S; Tachibana, H1

Other Studies

8 other study(ies) available for suplatast tosilate and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA‑3/IL‑5 signaling pathway in asthmatic rats.
    Molecular medicine reports, 2013, Volume: 8, Issue:1

    Topics: Airway Resistance; Animals; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Eosinophils; GATA3 Transcription Factor; Histamine Antagonists; Inflammation; Interleukin-5; Leukocyte Count; Lung; Male; Ovalbumin; Rats; Signal Transduction; Sulfonium Compounds

2013
The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2014, Volume: 62, Issue:1

    Topics: Animals; Arylsulfonates; Asthma; Chronic Disease; Disease Models, Animal; Histamine Antagonists; Lung; Male; Mice; Mice, Inbred BALB C; Sulfonium Compounds; Treatment Outcome

2014
Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
    Clinical immunology (Orlando, Fla.), 2003, Volume: 108, Issue:3

    Topics: Administration, Oral; Animals; Anti-Allergic Agents; Arylsulfonates; Benzimidazoles; Cell Count; Dermatitis, Allergic Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; Interleukin-4; Interleukin-5; Leukocyte Count; Lymph Nodes; Mice; Phthalazines; Picryl Chloride; Skin; Spleen; Sulfonium Compounds

2003
Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
    BJU international, 2007, Volume: 100, Issue:4

    Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Cystitis, Interstitial; Disease Models, Animal; Female; Rats; Rats, Sprague-Dawley; Sulfonium Compounds; T-Lymphocytes; Treatment Outcome

2007
[Antigen-induced airway hyperresponsiveness in infantile guinea pigs].
    Arerugi = [Allergy], 1998, Volume: 47, Issue:8

    Topics: Animals; Anti-Allergic Agents; Antigens; Arylsulfonates; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Guinea Pigs; Histamine Antagonists; Leukocyte Count; Male; Ovalbumin; Pyridines; Pyrimidinones; Respiratory Hypersensitivity; Sulfonium Compounds

1998
Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
    International archives of allergy and immunology, 2000, Volume: 121, Issue:2

    Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophilia; Female; Immunoglobulin E; Immunoglobulin G; Lung; Methacholine Chloride; Mice; Ovalbumin; Sulfonium Compounds

2000
Effects of suplatast tosilate, a new type of anti-allergic agent, on airway cough hypersensitivity induced by airway allergy in guinea-pigs.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2001, Volume: 31, Issue:12

    Topics: Airway Resistance; Animals; Anti-Allergic Agents; Arylsulfonates; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cough; Disease Models, Animal; Eosinophils; Guinea Pigs; Japan; Male; Ovalbumin; Respiratory Hypersensitivity; Sensitivity and Specificity; Sulfonium Compounds; Time Factors

2001